RHOB and cervical carcinoma: In cisplatin-resistant prostate and cervical cancer cells, lovastatin overcomes resistance by upregulating tumor suppressor genes such as Ras homolog family member B (RHOB) and kruppel-like factor 2 (KLF2) and 6 (KLF6) [138].